BA
LLY icon

Boston Advisors’s Eli Lilly LLY Stock Holding History

Boston Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8.55M Sell
76,431
-6,313
-8% -$703K 0.45% 51
2019
Q2 		$9.17M Sell
82,744
-16,051
-16% -$1.89M 0.49% 44
2019
Q1 		$12.8M Buy
98,795
+249
+0.3% +$30.3K 0.65% 28
2018
Q4 		$11.4M Buy
98,546
+2,173
+2% +$243K 0.66% 28
2018
Q3 		$10.3M Buy
96,373
+11,550
+14% +$1.15M 0.45% 46
2018
Q2 		$7.24M Sell
84,823
-1,552
-2% -$127K 0.18% 108
2018
Q1 		$6.68M Sell
86,375
-101,141
-54% -$8.14M 0.17% 126
2017
Q4 		$15.8M Sell
187,516
-1,130
-0.6% -$96.1K 0.34% 86
2017
Q3 		$16.1M Sell
188,646
-2,821
-1% -$231K 0.37% 83
2017
Q2 		$15.8M Sell
191,467
-19,711
-9% -$1.61M 0.36% 83
2017
Q1 		$17.8M Sell
211,178
-3,262
-2% -$261K 0.42% 67
2016
Q4 		$15.8M Sell
214,440
-13,453
-6% -$1M 0.38% 75
2016
Q3 		$18.3M Sell
227,893
-5,323
-2% -$426K 0.45% 69
2016
Q2 		$18.4M Sell
233,216
-402,868
-63% -$30.3M 0.46% 66
2016
Q1 		$45.8M Sell
636,084
-94,170
-13% -$7.13M 1.13% 12
2015
Q4 		$61.5M Buy
730,254
+425,101
+139% +$35.3M 1.44% 8
2015
Q3 		$25.5M Buy
305,153
+106,775
+54% +$9.01M 0.96% 10
2015
Q2 		$16.6M Sell
198,378
-234,113
-54% -$17.8M 0.69% 35
2015
Q1 		$31.4M Buy
432,491
+12,598
+3% +$897K 1.24% 9
2014
Q4 		$29M Sell
419,893
-24,776
-6% -$1.67M 1.22% 12
2014
Q3 		$28.8M Buy
444,669
+4,863
+1% +$308K 1.23% 9
2014
Q2 		$27.3M Buy
439,806
+7,078
+2% +$422K 1.17% 12
2014
Q1 		$25.5M Buy
432,728
+61,247
+16% +$3.42M 1.13% 15
2013
Q4 		$18.9M Sell
371,481
-20,647
-5% -$1.03M 0.9% 28
2013
Q3 		$19.7M Buy
392,128
+27,407
+8% +$1.43M 1.05% 17
2013
Q2 		$17.9M Buy
+364,721
New +$19.8M 0.86% 34

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Advisors's LLY Position: Q3 2019 in Review

Boston Advisors reduced its Eli Lilly (LLY) stake by 7.6% in Q3 2019, selling an estimated $703K and leaving 76,431 shares worth $8.55M. The position accounts for 0.45% of the portfolio, ranked #51.

Boston Advisors first reported a position in LLY in Q2 2013 and has held it in 26 quarters since. The position peaked at $61.5M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Boston Advisors held 76,431 shares of Eli Lilly worth $8.55M as of Q3 2019.
  • Boston Advisors sold 6,313 Eli Lilly shares in Q3 2019, an estimated $703K.
  • Eli Lilly made up 0.45% of Boston Advisors's portfolio in Q3 2019, its #51 holding.
  • Boston Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Eli Lilly position peaked at $61.5M in Q4 2015.
  • 1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.